Turmeric and Atovaquone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Turmeric and Atovaquone. Common interactions include dysphonia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people who take Turmeric and Atovaquone have. It is created by eHealthMe based on reports of 16 people who take Turmeric and Atovaquone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 05, 2022

16 people who take Turmeric and Atovaquone together, and have interactions are studied.


What is Turmeric?

Turmeric has active ingredients of turmeric. It is often used in inflammation. eHealthMe is studying from 12,033 Turmeric users for its effectiveness, alternative drugs and more.

What is Atovaquone?

Atovaquone has active ingredients of atovaquone. eHealthMe is studying from 3,810 Atovaquone users for its effectiveness, alternative drugs and more.

Number of Turmeric and Atovaquone reports submitted per year:

Turmeric and Atovaquone drug interactions.

Common Turmeric and Atovaquone drug interactions by gender *:

female:

  1. Dysphonia
  2. Adverse drug reaction
  3. Diarrhoea
  4. Drug intolerance
  5. Fatigue
  6. Gait disturbance
  7. Myelosuppression
  8. Neuropathy peripheral
  9. Oedema peripheral
  10. Peripheral swelling

male:

  1. Anxiety
  2. Cough
  3. Hypersensitivity
  4. Loss of consciousness
  5. Myocardial infarction
  6. Neutropenia
  7. Rash
  8. Sepsis
  9. Oral discharge
  10. Respiratory distress

Common Turmeric and Atovaquone drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Thrombosis
  2. Ulcer haemorrhage
  3. Dysphonia
  4. Pulmonary embolism

60+:

  1. Cerebrovascular accident
  2. Drug intolerance
  3. Myocardial infarction
  4. Neutropenia
  5. Rash
  6. Red blood cell count decreased
  7. Sepsis
  8. White blood cell count decreased

Common conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 12 people, 75.00%
  2. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord): 3 people, 18.75%
  3. Burkitt Lymphoma (cancer of the lymphatic system): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Turmeric and Atovaquone?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Turmeric and Atovaquone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Turmeric interactions:

Browse all interactions between Turmeric and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atovaquone interactions:

Browse all interactions between Atovaquone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on turmeric and atovaquone (the active ingredients of Turmeric and Atovaquone, respectively), and Turmeric and Atovaquone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Turmeric and Atovaquone.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: